Hauser SL, et al. Efficacy and safety of ofatumumab versus teriflunomide in relapsing multiple sclerosis: results of the phase 3 ASCLEPIOS I and II trials. Abstract 336. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Podcast voor coassistenten: basaal en praktisch
nov 2023 | Bewegingsstoornissen, Dementie, Epilepsie, Multipele Sclerose, Neuro-musculair, Neuro-oncologie, Neuro-vasculair